SCHEMBL4888958

SCHEMBL4888958

CCc1ccc(-c2ccccc2)cc1N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.53
HSD17B10 Q99714 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
HPGD P15428 2/20 0.53
KDM4E B2RXH2 1/20 0.53
USP2 O75604 1/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
HSP90AA1 P07900 1/20 0.53
GAA P10253 1/20 0.53
ALOX15 P16050 1/20 0.53
ALOX12 P18054 1/20 0.53
HTT P42858 1/20 0.53
IKBKB O14920 1/20 0.47
HDAC3 O15379 2/20 0.46
HDAC1 Q13547 2/20 0.46
HDAC2 Q92769 2/20 0.46
MAOA P21397 1/20 0.45
TDP1 Q9NUW8 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31570069 1.00 MAPT (0.53) MAPTHSD17B10MEN1KMT2AHPGD
SCHEMBL8369434 0.86 IKBKB (0.50) MAPTHSD17B10MEN1KMT2AHPGD
SCHEMBL16298594 0.83 GAA (0.41) MAPTHSD17B10MEN1KMT2AHPGD
SCHEMBL3785609 0.83 HSD17B10 (0.53) MAPTHSD17B10MEN1KMT2AHPGD
SCHEMBL28992451 0.83 DCLRE1A (0.47) MAPTMEN1KMT2AHPGDALDH1A1
SCHEMBL30380433 0.83 DCLRE1A (0.47) MAPTMEN1KMT2AHPGDALDH1A1
SCHEMBL19199865 0.82 HSD17B10 (0.52) MAPTHSD17B10MEN1KMT2AHPGD
SCHEMBL559918 0.82 ALDH1A1 (0.41) MAPTHSD17B10MEN1KMT2AHPGD
SCHEMBL27868391 0.82 MAPT (0.52) MAPTHSD17B10MEN1KMT2AHPGD
SCHEMBL3793580 0.82 HSD17B10 (0.57) MAPTHSD17B10MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214845-A1 ANTIBACTERIAL 6'-MODIFIED 4,5-SUBSTITUTED AMINOGLYCOSIDE ANALOGS ISIS PHARMACEUTICALS, INC. (US) 2008-09-04 US disclosed
WO-2007028012-A2 ANTIBACTERIAL 6'-N-MODIFIED 4,5-SUBSTITUTED AMINOGLYCOSIDE ANALOGS ISIS PHARMACEUTICALS, INC. (US) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214845-A1 ANTIBACTERIAL 6'-MODIFIED 4,5-SUBSTITUTED AMINOGLYCOSIDE ANALOGS FUT6, ALG8, NRDC MAPT 4625/4885HSD17B10 4143/4885MEN1 3264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.